Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids

Inclusion Criteria:

* Are premenopausal and ≥ 25 years old
* Have symptomatic uterine fibroids
* Have a uterine gestational size ≤14 weeks as determined by pelvic exam
* Have ≤ 6 (six) treatable fibroids in whom no single fibroid exceeds 7 cm in any diameter as measured by ultrasound or magnetic resonance imaging (MRI). Only Fibroids greater than 1cm in diameter should be treated in this study
* Have a total uterine fibroid volume that does not exceed 300cc on ultrasound or contrast-enhanced MRI evaluation
* Have clinical menorrhagia as indicated by menstrual blood loss of ≥160 mL to 500 ml during one baseline cycle or two baseline cycles within three months prior to treatment
* Have a history of at least 3 months of menorrhagia within the last six months
* Desire uterine preservation
* Do not desire current or future childbearing
* Have a normal coagulation profile international normalized ratio (INR), Platelets, Prothrombin Time, and Partial Thromboplastin Time (PTT)
* Have had a normal Pap smear within the past 12 months
* Are practicing non-hormonal or stable hormonal contraception
* If the woman is not currently taking any hormonal contraceptives, has been off all hormonal contraceptives for a minimum of three months prior to study enrollment, and agrees to continue without change in regimen through the 12 months of follow-up OR
* If the woman is currently taking hormonal contraceptives, has taken hormonal contraceptives for a minimum of three months prior to study enrollment, and agrees to continue without change in regimen through 12 months of follow up.\*\*

  \*\*Note: Hormonal contraceptive use must be terminated 30 days prior to treatment but should be resumed post-operatively within 60 days post treatment as instructed by the Investigator.
* Are willing and able to comply with all study tests, procedures, and assessment tools
* Are willing and able to return for all required follow up visits following study enrollment
* Must pass a pre-operative health exam (ASA I-III)
* Are capable of providing informed consent

Exclusion Criteria:

* Have contraindications for laparoscopic surgery and/or general anesthesia. (Contraindications include anemia, defined as a hemoglobin level under 10 or hematocrit level less than 30.)
* Have had prior pelvic surgery (with the exception of C-section, tubal ligation, or diagnostic laparoscopy), or are known to have significant intra-abdominal adhesions (defined as adhesions that would require extensive dissection to mobilize and view all surfaces of the uterus)
* Have previously undergone endometrial ablation, uterine artery embolization, or uterine artery ligation, or any other uterine-preserving technique for reduction of menstrual bleeding (with the exception of hysteroscopic myomectomy \> 1 year ago)
* Patients requiring elective concomitant procedures
* Have contraindications for magnetic resonance imaging (MRI)
* Desire current or future childbearing
* Are pregnant or lactating
* Have taken any Gonadotropin-releasing hormone (GnRh) agonist within three months prior to the screening procedures
* Have an implanted intrauterine or fallopian tube device for contraception that cannot or will not be removed one month prior to treatment
* Have dysfunctional uterine bleeding or bleeding between periods
* Have chronic pelvic pain not due to uterine fibroids
* Have known or suspected endometriosis
* Have known or suspected adenomyosis based on Ultrasound or MRI findings
* Have active or history of pelvic inflammatory disease
* Have a history of or evidence of gynecologic malignancy or pre-malignancy within the past five years
* Have had pelvic radiation
* Have a non-uterine pelvic mass
* Have a cervical myoma
* Have one or more pedunculated subserosal fibroids or "type zero" (completely intracavitary) submucous fibroids
* Are peri-menopausal (defined as women 40 years of age or older with Follicular Stimulating Hormone level of ≥ 25 International Units (IU) or menopausal
* Are unable to give informed consent
* In the medical judgment of the investigator should not participate in the study